Cell cycle kinases as therapeutic _targets for cancer
- PMID: 19568282
- DOI: 10.1038/nrd2907
Cell cycle kinases as therapeutic _targets for cancer
Abstract
Several families of protein kinases orchestrate the complex events that drive the cell cycle, and their activity is frequently deregulated in hyperproliferative cancer cells. Although several molecules that inhibit cell cycle kinases have been developed and clinically screened as potential anticancer agents, none of these has been approved for commercial use and an effective strategy to specifically control malignant cell proliferation has yet to be established. However, recent genetic and biochemical studies have provided information about the requirement for certain cell cycle kinases by specific tumours and specialized tissue types. Here, we discuss the potential and limitations of established cell cycle kinases as _targets in anticancer drug discovery as well as novel strategies for the design of new agents.
Similar articles
-
[The serine/threonine kinases that control cell cycle progression as therapeutic _targets].Bull Cancer. 2011 Nov;98(11):1335-45. doi: 10.1684/bdc.2011.1467. Bull Cancer. 2011. PMID: 22020767 Review. French.
-
Therapeutic opportunities to control tumor cell cycles.Clin Transl Oncol. 2006 Jun;8(6):399-408. doi: 10.1007/s12094-006-0193-7. Clin Transl Oncol. 2006. PMID: 16790392 Review.
-
Tubulin-associated drug _targets: Aurora kinases, Polo-like kinases, and others.Semin Oncol. 2006 Aug;33(4):436-48. doi: 10.1053/j.seminoncol.2006.04.007. Semin Oncol. 2006. PMID: 16890798 Review.
-
[Novel anti-cancer compounds _targeting the cell cycle].Nihon Yakurigaku Zasshi. 2009 Jan;133(1):27-31. doi: 10.1254/fpj.133.27. Nihon Yakurigaku Zasshi. 2009. PMID: 19145048 Review. Japanese. No abstract available.
-
Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors.Molecules. 2021 Aug 26;26(17):5170. doi: 10.3390/molecules26175170. Molecules. 2021. PMID: 34500603 Free PMC article. Review.
Cited by
-
Fluorescent Peptide Biosensors for Probing CDK Kinase Activity in Cell Extracts.Methods Mol Biol. 2021;2329:39-50. doi: 10.1007/978-1-0716-1538-6_4. Methods Mol Biol. 2021. PMID: 34085214
-
The history and future of _targeting cyclin-dependent kinases in cancer therapy.Nat Rev Drug Discov. 2015 Feb;14(2):130-46. doi: 10.1038/nrd4504. Nat Rev Drug Discov. 2015. PMID: 25633797 Free PMC article. Review.
-
Apaf-1- and Caspase-8-independent apoptosis.Cell Death Differ. 2013 Feb;20(2):343-52. doi: 10.1038/cdd.2012.149. Epub 2012 Nov 30. Cell Death Differ. 2013. PMID: 23197294 Free PMC article.
-
Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy.Pathol Oncol Res. 2012 Oct;18(4):761-9. doi: 10.1007/s12253-012-9534-8. Epub 2012 Jul 29. Pathol Oncol Res. 2012. PMID: 22843098 Review.
-
Evolution of resistance to Aurora kinase B inhibitors in leukaemia cells.PLoS One. 2012;7(2):e30734. doi: 10.1371/journal.pone.0030734. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359551 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources